Europe — EMA
Olmesartan/Amlodipin Krka (Olmesartan Medoxomil, Amlodipine)
Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin Krka, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin Krka, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults. It combines olmesartan with a calcium‑channel blocker to improve blood pressure control.
GNH USA supplies Olmesartan/Amlodipin Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan/Amlodipin Krka is used in cardiovascular therapy, targeting blood pressure regulation pathways. - Hypertension: Helps to achieve target blood pressure levels and reduces cardiovascular risk. - Chronic kidney disease with hypertension: Assists in slowing the progression of kidney function decline. - Heart failure with reduced ejection fraction: Provides additional blood‑pressure lowering benefit when added to standard therapy. - Stable diabetes and vascular risk for patients with both hypertension and a the the the t t t
